June 23-24 OneMedForum New York
OneMedPlace Trans-Atlantic Conference on June 23rd-24th is a gathering of fast growing, emerging healthcare and life science companies in Europe and North America. Its sixth […]
Video
Is Europe A Better Place To Build A Medical Technology Company? (Video)
Growth in the life sciences industries will greatly depend on how the FDA responds to growing complaints that they are stifling medical technologies.
Killing Canine Cancer:Functional Nutriments Applies Ground-Breaking Therapy To Human Patients (Video)
Cancer, a word that strikes a chord of fear in many, is a fighting word. At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry, and while it is a match we have yet to win, researchers and scientists have on their boxing gloves and are staying in the fight.
A Heart To Heart Talk On The Future Of Cardiology (Video)
According to the American Heart Association, more than 13 million people suffer from coronary heart disease, 6 million from angina, and 7 million from myocardial infraction. Rapid technological advances and product innovation are transforming the cardiology market.
OneMedPlace Brings 17 Diverse Workshop Sessions With New Inspirations To All Involved
This year at OneMedForum San Francisco, OneMedPlace offered 17 workshop sessions on a variety of subjects helping investors grow their businesses.
Advanced Life Sciences Announces Two New Achievements
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
A New Treatment for Macular Degeneration
If you are interested in learning more about this company or technology complete the form below. First*: Last*: Company / Organization*: Email*: Comments or questions: […]
Ischemic Stroke: Challenging Market, Huge Need
Time is critical when a patient suffers from a stroke.
Advanced Life Sciences: Addressing Antibiotic Resistance in Infectious Disease Market
The company’s lead product is Restanza (cethromycin), a novel once-a-day antibiotic for the treatment of life-threatening bacterial infections and bioterror pathogens.